Christer de Flon
Directeur Général chez Blå Stjärnans Djursjukhus Forvaltnings AB
Postes actifs de Christer de Flon
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Blå Stjärnans Djursjukhus Forvaltnings AB
 Blå Stjärnans Djursjukhus Forvaltnings AB Agricultural Commodities/MillingProcess Industries Part of Stift Svenska Blå Stjärnans Djursjukh i Gbg, Blå Stjärnans Djursjukhus Forvaltnings AB is a veterinary services company based in Gothenburg, Sweden. The Swedish company provides veterinary services. The CEO of the company is Christer de Flon. | Directeur Général | 31/05/2010 | - |
Historique de carrière de Christer de Flon
Anciens postes connus de Christer de Flon
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| XVIVO PERFUSION AB | Sales & Marketing | 01/01/2013 | - |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Corporate Officer/Principal | - | - |
| Astra Hässle AB | Corporate Officer/Principal | - | - |
| VITROLIFE AB | Corporate Officer/Principal | - | - |
A. Carlsson Research AB
 A. Carlsson Research AB Pharmaceuticals: MajorHealth Technology Part of NTG Nordic Transport Group A/S, A. Carlsson Research AB develops and discovers new pharmacological treatment principles for psychiatric and neurological disorders. The company is based in Gothenburg, Sweden. The CEO of the Swedish company is Arvid M. Carlsson. A. Carlsson Research was acquired by NTG Nordic Transport Group A/S on October 23, 2006 for $121.91 million. | President | - | - |
| ORTOMA AB | Directeur/Membre du Conseil | 21/10/2009 | - |
Formation de Christer de Flon
| University of Gothenburg | Graduate Degree |
Statistiques
Internationale
| Suède | 9 |
Opérationnelle
| Corporate Officer/Principal | 3 |
| Director/Board Member | 1 |
| President | 1 |
Sectorielle
| Health Technology | 4 |
| Health Services | 2 |
| Process Industries | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| ORTOMA AB | Health Services |
| VITROLIFE AB | Health Technology |
| XVIVO PERFUSION AB | Health Technology |
| Entreprise privées | 4 |
|---|---|
A. Carlsson Research AB
A. Carlsson Research AB Pharmaceuticals: MajorHealth Technology Part of NTG Nordic Transport Group A/S, A. Carlsson Research AB develops and discovers new pharmacological treatment principles for psychiatric and neurological disorders. The company is based in Gothenburg, Sweden. The CEO of the Swedish company is Arvid M. Carlsson. A. Carlsson Research was acquired by NTG Nordic Transport Group A/S on October 23, 2006 for $121.91 million. | Health Technology |
Blå Stjärnans Djursjukhus Forvaltnings AB
Blå Stjärnans Djursjukhus Forvaltnings AB Agricultural Commodities/MillingProcess Industries Part of Stift Svenska Blå Stjärnans Djursjukh i Gbg, Blå Stjärnans Djursjukhus Forvaltnings AB is a veterinary services company based in Gothenburg, Sweden. The Swedish company provides veterinary services. The CEO of the company is Christer de Flon. | Process Industries |
| Astra Hässle AB | |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
- Bourse
- Insiders
- Christer de Flon
- Expérience
